The Virtual Child.


Journal

Cancer discovery
ISSN: 2159-8290
Titre abrégé: Cancer Discov
Pays: United States
ID NLM: 101561693

Informations de publication

Date de publication:
04 Apr 2024
Historique:
medline: 4 4 2024
pubmed: 4 4 2024
entrez: 4 4 2024
Statut: ppublish

Résumé

We are building the world's first Virtual Child-a computer model of normal and cancerous human development at the level of each individual cell. The Virtual Child will "develop cancer" that we will subject to unlimited virtual clinical trials that pinpoint, predict, and prioritize potential new treatments, bringing forward the day when no child dies of cancer, giving each one the opportunity to lead a full and healthy life.

Identifiants

pubmed: 38571421
pii: 741971
doi: 10.1158/2159-8290.CD-23-1500
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

663-668

Informations de copyright

©2024 American Association for Cancer Research.

Auteurs

Richard J Gilbertson (RJ)

CRUK Cambridge Institute, University of Cambridge, Cambridge, United Kingdom.
Department of Oncology, University of Cambridge, Cambridge, United Kingdom.

Sam Behjati (S)

Wellcome Sanger Institute, Hinxton, United Kingdom.
Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom.
Department of Paediatrics, University of Cambridge, Cambridge, United Kingdom.

Anna-Lisa Böttcher (AL)

Hopp Children's Cancer Center (KiTZ), Heidelberg, Germany.
Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), Heidelberg, Germany.

Marianne E Bronner (ME)

Division of Biology and Biological Engineering, California Institute of Technology, Pasadena, California.

Matthew Burridge (M)

Amazon Web Services, London, United Kingdom.

Harry Clifford (H)

NVIDIA, Cambridge, United Kingdom.

Tracey Danaher (T)

Children's Cancer Foundation, Australia.

Laura K Donovan (LK)

University College London Great Ormond Street Institute of Child Health, United Kingdom.

Jarno Drost (J)

Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.
Oncode Institute, Utrecht, the Netherlands.

Alexander M M Eggermont (AMM)

Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.

Chris Emerson (C)

NVIDIA, Cambridge, United Kingdom.

Mona G Flores (MG)

NVIDIA, Santa Clara, California.

Petra Hamerlik (P)

University of Manchester, Manchester, United Kingdom.

Nada Jabado (N)

Department of Paediatrics, Research Institute of the McGill University Health Centre, Montreal, Quebec, Canada.

Andrew Jones (A)

Amazon Web Services, London, United Kingdom.

Henrick Kaessmann (H)

Center for Molecular Biology of Heidelberg University (ZMBH), Heidelberg, Germany.

Claudia L Kleinman (CL)

Lady Davis Research Institute, Jewish General Hospital, Montreal, Quebec, Canada.
Department of Human Genetics, McGill University, Montreal, Quebec, Canada.

Marcel Kool (M)

Hopp Children's Cancer Center (KiTZ), Heidelberg, Germany.
Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), Heidelberg, Germany.
Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.

Lena M Kutscher (LM)

Hopp Children's Cancer Center (KiTZ), Heidelberg, Germany.
Developmental Origins of Pediatric Cancer Junior Research Group, German Cancer Research Center (DKFZ), Heidelberg, Germany.

Gavin Lindberg (G)

The EVAN Foundation, Maryland.

Emily Linnane (E)

CRUK Cambridge Institute, University of Cambridge, Cambridge, United Kingdom.
Department of Oncology, University of Cambridge, Cambridge, United Kingdom.

John C Marioni (JC)

CRUK Cambridge Institute, University of Cambridge, Cambridge, United Kingdom.
Wellcome Sanger Institute, Hinxton, United Kingdom.
European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome Genome Campus, Cambridge, United Kingdom.

John M Maris (JM)

Division of Oncology and Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.
Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania.

Michelle Monje (M)

Department of Neurology and Neurological Sciences, Stanford University, Stanford, California.

Alexandra Macaskill (A)

AstraZeneca, Oncology R&D, Cambridge, United Kingdom.

Steven Niederer (S)

Turing Research and Innovation Cluster in Digital Twins (TRIC: DT), The Alan Turing Institute, London, United Kingdom.

Paul A Northcott (PA)

Department of Developmental Neurobiology, St Jude Children's Research Hospital, Memphis, Tennessee.

Elizabeth Peeters (E)

b.r.a.i.n.child, SickKids Hospital, Toronto, Ontario, Canada.

Willemijn Plieger-van Solkema (W)

Dutch Childhood Cancer Organization (VKKN), the Netherlands.

Anne C Rios (AC)

Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.

Karsten Rippe (K)

German Cancer Research Center (DKFZ) Heidelberg, Division of Chromatin Networks, Heidelberg, Germany.

Peter Sandford (P)

Amazon Web Services, London, United Kingdom.

Nikolaos G Sgourakis (NG)

Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania.
Department of Pathology and Lab Medicine, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.

Adam Shlien (A)

Genetics and Genomics Program, The Hospital for Sick Children, Toronto, Canada.

Pete Smith (P)

Hula Therapeutics, Philadelphia, Pennsylvania.

Karin Straathof (K)

University College London Cancer Institute, London, United Kingdom.
Great Ormond Street Hospital for Children, London, United Kingdom.

Patrick J Sullivan (PJ)

Team Finn Foundation, Vancouver, British Columbia, Canada.

Mario L Suvà (ML)

Department of Pathology and Center for Cancer Research, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts.
Broad Institute of MIT and Harvard, Boston, Massachusetts.

Michael D Taylor (MD)

Texas Children's Cancer Center, Hematology-Oncology Section and Department of Pediatrics - Hematology/Oncology and Neurosurgery, Baylor College of Medicine, Houston, Texas.

Emma Thompson (E)

Brain Tumour Charity, Fleet, United Kingdom.

Roser Vento-Tormo (R)

Wellcome Sanger Institute, Hinxton, United Kingdom.

Brandon J Wainwright (BJ)

The University of Queensland Frazer Institute, Translational Research Institute, Woolloongabba, Queensland, Australia.

Robert J Wechsler-Reya (RJ)

Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York, New York.

Frank Westermann (F)

Hopp Children's Cancer Center (KiTZ), Heidelberg, Germany.
Division of Neuroblastoma Genomics, German Cancer Research Center (DKFZ), Heidelberg, Germany.

Shannon Winslade (S)

Brain Tumour Charity, Fleet, United Kingdom.

Bissan Al-Lazikani (B)

Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.

Stefan M Pfister (SM)

Hopp Children's Cancer Center (KiTZ), Heidelberg, Germany.
Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), Heidelberg, Germany.

Classifications MeSH